University of Maryland School of Medicine
Muhammad Mansoor Mohiuddin, MD/MBBS, DSc(Hon), FAST
Dr. Mohiuddin currently serves as a tenured Professor of Surgery and Director of the cardiac xenotransplantation program at the University of Maryland School of Medicine (UMSOM), Baltimore, MD.He has been involved in Xenotransplantation Research since 1991.He is Associate Editor for Transplantation and reviews manuscripts for many other journals. He is also the past president Dow Graduate Association of North America. His achievements include several NIH and non-NIH grants during his academic career. He is a member of the executive committee of the Community of Transplant Scientists (COTS) and a member of the advisory council of transplant regenerative medicine of the American Society of Transplantation (AST)
Dr. Mohiuddin's career has been a testament to his pioneering spirit in Xenotransplantation. His groundbreaking contributions include demonstrating the most prolonged survival in heterotopic and orthotopic cardiac Xenotransplantation. He devised an immunosuppression regimen that significantly extended the lifespan of cardiac xenografts to nearly three years. His leadership extends to the International Xenotransplantation Association (IXA), where he now serves as President. His extensive publication record includes over 150 papers and more than 200 abstracts, and he has been a sought-after expert speaker on Xenotransplantation.
Dr. Mohiuddin's unwavering dedication to Xenotransplantation culminated in two significant milestones. On January 7, 2022, he achieved the First Genetically Engineered pig-to-human cardiac Xenotransplantation. He then led the second xenotransplantation procedure in September 2023, further solidifying his position as a leader in the field.
Besides other awards, Dr Mohiuddin was picked by Nature Journal as one of the “Nature’s 10” in 2022. Ten people who helped shape science in 2022. He was also selected as Influential Marylanders in 2024
Also, Dr. Mohiuddin is on the board of the AST Transplant Regenerative Medicine Advisory Council and on executive council of community of transplant scientists.
Disclosure information not submitted.
Thought Leader: The Remarkable Potential of Xenotransplantation (Max Harry Weil Honorary Lecture)
Tuesday, February 25, 2025
1:30pm – 2:15pm Eastern Time